Company intelligence
FluoSphera
The only company with a suite of systemic and high-throughput in vitro drug discovery solutions
About FluoSphera
FluoSphera S.A. is the only company providing a suite of high-throughput, systemic, in vitro drug discovery solutions. Its proprietary chip-free platform uses flexible 3D cell systems that mimic the complex biology of the human body to rapidly and precisely study human response to systemic drug delivery. FluoSphera offers four distinct drug discovery solutions: (1) multiplexing for target selectivity, (2) measuring systemic efficacy and toxicity, (3) systemic biomarker identification, and (4) translational species optimization.
Verified activity
Signals from FluoSphera
2 published signals
Products & Services
FluoSphera launched a new website featuring its technology, applications, and solutions for drug discovery and preclinical studies.
Reported by FluoSphera
Legal & Regulatory
FluoSphera has licensed Debiopharm’s AbYlink™ antibody conjugation technology to expand its capabilities for ADCs, bispecific antibodies, and other antibody-based therapeutics.
Reported by FluoSphera